Previous studies have found increased activities of SOD, CAT, markers of lipid peroxidation and decreased activities of glutathione peroxidase (GPx) in pharmacoresistant temporal lobe epilepsy (TLE) patients [35,36]. The gene discussed is SOD1; the disease is temporal lobe epilepsy.